The safety and tolerability of a multi-species probiotic formulation in chemotherapy-induced intestinal mucositis/diarrhoea: an exploratory end-point pilot study
MultibioticTM is a multi-species probiotic formulation consisting of lactobacilli and bifidobacteria predominately, that has been laboratory and clinically evaluated to improve the stability of the intestinal microbial cohort, especially during and after the administration of pharmaceutical medicines such as antibiotics, proton pump inhibitors, analgesic medications and other.
National Institute of Integrative Medicine (NIIM) EC00436
NIIM HREC | 0043E_2017
Northern Cancer Institute, 38 Pacific Hwy, St Leonards NSW 2065
Recruiting January 2019